Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical recapitulation of antiangiogenic drug clinical efficacies using models of early or late stage breast cancer metastatis

Published:2013-08 Issue: Volume:22 Page:S57-S65
ISSN:0960-9776
Container-title:The Breast
language:en
Short-container-title:The Breast

Author:

Kerbel Robert S.,Guerin Eric,Francia Giulio,Xu Ping,Lee Christina R.,Ebos John M.L.,Man Shan

Funder

Ontario Institute for Cancer Research

Canadian Breast Cancer Foundation

National Institutes of Health (NIH), USA

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference61 articles.

1. What's wrong with our cancer models?;Kamb;Nat Rev Drug Discov,2005

2. Practices and pitfalls of mouse cancer models in drug discovery;Kung;Adv Cancer Res,2007

3. Murine models to evaluate novel and conventional therapeutic strategies for cancer;Talmadge;Am J Pathol,2007

4. Perspective: mouse models of advanced spontaneous metastasis for experimental therapeutics;Francia;Nat Rev Cancer,2011

5. Human tumor xenografts as predictive preclinical models for anticancer drug activity in humans: better than commonly perceived – but they can be improved;Kerbel;Cancer Biol Ther,2003

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Power and Promise of Patient-Derived Xenografts of Human Breast Cancer;Cold Spring Harbor Perspectives in Medicine;2023-12-05

2. Optimized scaling of translational factors in oncology: from xenografts to RECIST;Cancer Chemotherapy and Pharmacology;2022-08-03

3. Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models;Cancer Research;2022-04-11

4. Metronomic chemotherapy and antiangiogenic drugs: Preclinical and clinical data;Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy;2022

5. Leishmania-infected macrophages release extracellular vesicles that can promote lesion development;Life Science Alliance;2020-10-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3